Pertussis antigens--screening models on toxicity

Area of Science:

• Immunology
• Vaccine Development
• Microbiology

Background:

• Diphtheria-tetanus-pertussis (DPT) vaccines are crucial for preventing bacterial infections.
• Production methods for pertussis vaccines can influence their toxicity and efficacy.
• Understanding antigen extraction and harvesting techniques is vital for vaccine safety.

Purpose of the Study:

• To compare the toxicity of two DPT-vaccine types produced using different B. pertussis harvesting methods.
• To evaluate the safety profile of whole inactivated bacteria versus extracted antigen complex vaccines.
• To assess the impact of centrifugation versus acid precipitation on vaccine toxicity.

Main Methods:

• Production of two DPT-vaccine batches from B. pertussis: one with whole inactivated bacteria, another with extracted antigens.
• Harvesting methods included centrifugation and acid precipitation.
• Toxicity assessment using multiple animal models: mouse-weight-gain assay, mouse leukocytosis test, histamine sensitization, rat allergic encephalitis, and Limulus assay.

Main Results:

• Vaccines containing whole inactivated B. pertussis bacteria exhibited higher toxicity compared to vaccines with extracted antigen complexes.
• Cell material harvested via centrifugation demonstrated lower toxicity than that obtained through acid precipitation.
• The Limulus assay indicated differences in endotoxin levels correlating with observed toxicity.

Conclusions:

• Vaccine production methods significantly impact the toxicity of DPT vaccines.
• Extracted antigen vaccines are potentially safer than whole bacteria vaccines.
• Centrifugation is a preferable harvesting method over acid precipitation for reducing vaccine toxicity.